BY: LILLY GOODMAN, STAFF WRITER Album cover from albumoftheyear.org The Weeknd’s new sixth studio album, “Hurry Up Tomorrow,” ...

Evercore ISI analyst Umer Raffat maintained a Buy rating on Biogen (BIIB – Research Report) yesterday. The company’s shares closed yesterday at ...

Eli Lilly LLY-N on Thursday suggested that demand for its popular diabetes and weight-loss treatments was not a concern, easing investor agitation about signs of weakness in sales of the drugs.

Eli Lilly, the world’s biggest drugmaker by market value, reported higher-than-expected quarterly profit and issued a bullish earnings forecast. Sales of weight-loss drug Zepbound and diabetes ...

This week on The Backstage Experience we take you backstage with the biggest names and games in the Marvel Cinematic Universe. Guests include Chris Pratt, Chris Hemsworth, Chris Evans, Josh Brolin, ...

Goodman has been betting big on data centres on the belief that they will be needed to cope with the heavy demands of AI. In its most recent quarterly update, Goodman's CEO, Greg Goodman ...

Cryptocurrency market leader bitcoin is trading above $US102,000. The Aussie dollar is trading around US62.50c.

In a report released today, Terence Flynn from Morgan Stanley reiterated a Buy rating on Eli Lilly & Co (LLY – Research Report), with a price target of $1,146.00. The company’s shares closed ...

If Eli Lilly has its way, this may be the future of obesity care. Eli Lilly makes some of the most powerful weight-loss drugs in the world. The company has pivoted dramatically over the past ...

Eli Lilly is experiencing explosive growth thanks to its diabetes and obesity treatments. Beyond weight loss, the company is quietly building a fast-growing oncology business. This is an enormous ...